The SMILE trial will seek to identify individuals at high risk for developing lupus and treat them before they ever transition into the disease.
The Eastern Star has now donated a total of $331,058 to OMRF research since 2002.
Morris Reichlin helped build OMRF into one of the world’s leading centers for lupus research and treatment.
These findings will help scientists understand how to better diagnose and treat the disease.
The foundation hopes to recruit up to 2,000 healthy individuals.
The gene, NCF1, was known by researchers, but it had not previously been linked to lupus